全文获取类型
收费全文 | 567篇 |
免费 | 36篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 24篇 |
妇产科学 | 7篇 |
基础医学 | 52篇 |
口腔科学 | 9篇 |
临床医学 | 36篇 |
内科学 | 129篇 |
皮肤病学 | 6篇 |
神经病学 | 14篇 |
特种医学 | 168篇 |
外科学 | 66篇 |
综合类 | 15篇 |
预防医学 | 17篇 |
眼科学 | 5篇 |
药学 | 19篇 |
肿瘤学 | 46篇 |
出版年
2022年 | 2篇 |
2021年 | 2篇 |
2020年 | 5篇 |
2019年 | 6篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2015年 | 10篇 |
2014年 | 11篇 |
2013年 | 15篇 |
2012年 | 11篇 |
2011年 | 16篇 |
2010年 | 9篇 |
2009年 | 19篇 |
2008年 | 17篇 |
2007年 | 25篇 |
2006年 | 19篇 |
2005年 | 21篇 |
2004年 | 18篇 |
2003年 | 10篇 |
2002年 | 4篇 |
2001年 | 18篇 |
2000年 | 18篇 |
1999年 | 20篇 |
1998年 | 25篇 |
1997年 | 27篇 |
1996年 | 24篇 |
1995年 | 10篇 |
1994年 | 17篇 |
1993年 | 9篇 |
1992年 | 13篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 15篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 11篇 |
1985年 | 18篇 |
1984年 | 11篇 |
1983年 | 21篇 |
1982年 | 21篇 |
1981年 | 17篇 |
1980年 | 14篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1920年 | 1篇 |
排序方式: 共有617条查询结果,搜索用时 15 毫秒
1.
Roger F Uren 《Journal of nuclear medicine》2006,47(2):191-195
2.
3.
4.
Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results 总被引:3,自引:0,他引:3
Mattrey RF; Strich G; Shelton RE; Gosink BB; Leopold GR; Lee T; Forsythe J 《Radiology》1987,163(2):339-343
In animals, perfluorochemicals (PFCs) are effective ultrasound (US) contrast agents that produce hepatic, splenic, and tumor enhancement. The use of Fluosol-DA 20%, an emulsion of perfluorodecalin and perfluorotripropylamine, was studied in nine non-critically ill patients with cancer who had liver lesions. US studies without Fluosol were compared with studies obtained 24, 48, and 72 hours after Fluosol infusion. Vital signs and extensive laboratory analyses are performed before and after Fluosol infusion. Liver metastases from colonic, pancreatic, and gastric carcinoma exhibited rim or diffuse enhancement after a Fluosol dose of 1.6 g/kg or greater. Fluosol produced echogenic enhancement of the liver and spleen relative to kidney at a dose of 2.4 g/kg, allowing the detection of nonenhancing lesions. In addition, Fluosol at a dose of 1.6 g/kg or greater allowed detection of lesions not seen before contrast medium was administered in three of the seven patients studied. There was a mild increase in the level of serum glutamic oxaloacetic transaminase in two patients, one given 2.4 and the other 3.2 g/kg of Fluosol. Mild and transient allergic reactions without change in vital signs were experienced by two patients. 相似文献
5.
A congenital intrapericardial aneurysmal dilatation of the left atrial wall was found in a 28 year old man who presented with atrial fibrillation after a syncopal event. The patient had cutaneous manifestations of neurofibromatosis. The diagnosis was made by cross sectional echocardiography and confirmed by angiocardiography. Surgical excision of the aneurysm resolved the symptoms. 相似文献
6.
7.
8.
Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients 总被引:4,自引:1,他引:3
Dr. Roger F. Uren MBBS Robert Howman-Giles MD John F. Thompson MD 《Annals of surgical oncology》1998,5(4):384-387
Background: Preoperative lymphoscintigraphy (LS) with99mTc antimony sulphide colloid is now part of the routine management of patients with intermediate thickness melanoma at the
Sydney Melanoma Unit. Over a 13-year period, 1375 patients have been examined using LS, and we have observed many unusual
lymphatic drainage pathways, including direct drainage through the body wall to retroperitoneal and paravertebral lymph nodes
from the skin of the back. The aim of this study was to determine the incidence of such drainage in the 542 patients who had
primary melanoma sites on the posterior trunk.
Methods: The lymphoscintigrams performed on these patients were examined for the presence of direct lymphatic drainage through the
posterior body wall to sentinel nodes in the retroperitoneal and paravertebral regions.
Results: Lymphatic drainage directly through the body wall to such lymph nodes occurred in 14 of these 542 patients.
Conclusions: Preoperative knowledge of the presence of this lymph drainage pattern may influence surgical management, and follow-up investigations
in these patients can be tailored to ensure that the relevant areas are examined with anatomic imaging or F18-FDG PET scans. 相似文献
9.
Dohle GR; Ramos L; Pieters MH; Braat DD; Weber RF 《Human reproduction (Oxford, England)》1998,13(3):620-623
Male genital tract obstructions may result from infections, previous
inguinal and scrotal surgery (vasectomy) and congenital bilateral absence
of the vas deferens (CBAVD). Microsurgery can sometimes be successful in
treating the obstruction. In other cases and in cases of failed surgical
intervention, the patient can be treated by microsurgical or percutaneous
epididymal sperm aspiration (MESA, PESA) or testicular sperm extraction
(TESE) and intracytoplasmic sperm injection (ICSI). We present the results
of 39 ICSI procedures for obstructive azoospermia in 24 couples. The
aetiology of the obstruction was failed microsurgery in 11 patients, CBAVD
in nine and genital infections in four. Sperm retrieval was accomplished
via MESA in four cases, PESA in 18 cases and via TESE in 11 cases. TESE was
only applied when PESA failed to produce enough spermatozoa for
simultaneous ICSI. In six patients, the ICSI procedure was performed with
cryopreserved spermatozoa after an initial PESA procedure. Fertilization
occurred in 47% of the metaphase II oocytes; embryo transfer was performed
in 92% of procedures and resulted in a clinical pregnancy in 13/39
procedures. Ongoing pregnancy was achieved in 10/39 procedures. One
pregnancy was terminated early after prenatal investigation showed a
cytogenetic abnormality (47,XX+18, Edwards syndrome). The other nine
pregnancies resulted in the live birth of 10 children, without any
congenital abnormalities. Epididymal and testicular retrieved spermatozoa
were successfully used for ICSI to treat obstructive azoospermia, and
resulted in an ongoing pregnancy in 10 of 24 couples (41.6%) after 39 ICSI
procedures, a success rate of 25.6% per treatment cycle and of 27.7% per
embryo transfer.
相似文献
10.